Functional analysis of a human tumor necrosis factor α (TNF-α) promoter polymorphism related to joint damage in rheumatoid arthritis

Molecular Medicine

Volumn 4, Issue 11, 1998, Pages 724-733

  Kaijzel, Eric L ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR4 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; DISEASE COURSE; DISEASE SEVERITY; DNA POLYMORPHISM; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HUMAN; HUMAN CELL; JOINT DESTRUCTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; RHEUMATOID ARTHRITIS;

EID: 0032436712     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401767     Document Type: Article

References (45)

1. Elliott MJ, Maini R, Feldmann M, et al. (1994) Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor a (cA2) versus placebo in rheumatoid arthritis. Lancet 344: 1105-1110.
2. Elliott MJ, Maini RN, Feldmann M, et al. (1994) Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis. Lancet 344: 1125-1127.
3. Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, Kollias G. (1991) Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 10: 4025-4031.
4. Marino MW, Dunn A, Grail D, et al. (1997) Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 94: 8093-8098.
5. Amiot F, Boussadia O, Cases S, et al. (1997) Mice heterozygous for a deletion of the tumor necrosis factor-α and lymphotoxin-α genes: biological importance of a non-linear response of tumor necrosis factor-α to gene dosage. Eur. J. Immunol. 27: 1035-1042.
6. Economou JS, Rhoades K, Essner R, McBride WH, Gasson JC, Morton D. (1989) Genetic analysis of the human tumor necrosis factor α/cachectin promoter region in a macrophage cell line. J. Exp. Med. 170: 321-326.
7. Goldfeld AE, Doyle C, Maniatis T. (1990) Human tumor necrosis factor α gene regulation by virus and lipopolysaccharide. Proc. Natl. Acad. Sci. U.S.A. 87: 9769-9773.
8. Beutler B. (1992) Application of transcriptional and posttranscriptional reporter constructs to the analysis of tumor necrosis factor gene regulation. Am. J. Med. Sci. 303: 129-133.
9. Jongeneel CV. (1994) Regulation of the TNFα gene. Prog. Clin. Biol. Res. 388: 367-381.
10. van Zeben D, Hazes JMW, Zwinderman AH, et al. (1991) Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a follow-up study. Arthritis Rheum. 43: 822-830.
11. D'Alfonso S, Momigliano Richiardi P. (1994) A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 39: 150-154.
12. Brinkman BMN, Huizinga TWJ, Kurban SS, et al. (1997) Tumour necrosis factor a gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Er. J. Rheumatol. 36: 516-521.
13. Vinasco J, Beraun Y, Nieto A, et al. (1997) Polymorphism at the TNF loci in rheumatoid arthritis. Tissue Antigens 49: 74-78.
14. Huizinga TWJ, Westendorp RGJ, Bollen ELEM, et al. (1997) TNF-α polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J. Neuroimmunol. 72: 149-153.
15. D'Alfonso S, Momigliano Richiardi P. (1996) An intragenic polymorphism in the human tumor necrosis factor alpha (TNFA) chain-encoding gene. Immunogenetics 44: 321-322.
16. Höhler T, Kruger A, Schneider PM, et al. (1997) A TNF-α promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. J. Invest. Dermatol. 109: 562-565.
17. Conway DJ, Holland MJ, Bailey RL, et al. (1997) Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-α) gene promoter and with elevated TNF-α levels in tear fluid. Infection Immunity 65: 1003-1006.
18. Grove J, Daly AK, Bassendine MF, Day CP. (1997) Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology 26: 143-146.
19. van Zeben D, Hazes JM, Zwinderman AH, Vandenbroucke JP, Breedveld FC. (1994) The severity of rheumatoid arthritis: a 6-year follow-up study of younger women with symptoms of recent onset. J. Rheumatol. 21: 1620-1625.
20. Arnett FC, Edworthy SM, Bloch DA, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31: 315-324.
21. van der Heijde DM, van Leeuwen MA, van Riel PL, van de Putte LB. (1995) Radiographie progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde's modification). J. Rheumatol. 22: 1792-1796.
22. Brinkman BMN, Zuijdgeest D, Kaijzel EL, Breedveld FC, Verweij CL. (1996) Relevance of the tumor necrosis factor alpha (TNFα) -308 promoter polymorphism in TNFa gene regulation. J. Imflam. 46: 32-41.
23. Nordeen SK. (1988) Luciferase reporter gene vectors for analysis of promoters and enhancers. BioTechniques 6: 454-457.
24. Sambrook J, Fritsch EF, Maniatis T. (1989) Molecular Cloning. A Laboratory Manual. Cold Spring Laboratory Press, Cold Spring, NY.
25. Sundstrom C, Nilsson K. (1976) Establishment and characterization of a human histiocytic cell line (U-937). M. J. Cancer 17: 565-577.
26. Ziegler-Heitbrock HWL, Thiel E, Fütterer A, Herzog V, Wirtz A, Riethmüller G. (1988) Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int. J. Cancer 41: 456-461.
27. Hill WG. (1974) Estimation of linkage disequilibrium in randomly mating populations. Heredity 33: 229-239.
28. Meulenbelt I, Williams CJ, Te Koppele JM, Van de Giessen GC, Slagboom PE. ( 1996) Population haplotype analysis and evolutionary relations of the COL2A1. Ann. Hum. Genet. 60: 189-199.
29. Hamann A, Mantzoros C, Vidal-Puig A, Flier JS. (1995) Genetic variability in the TNF-a promoter is not associated with type II diabetes mellitus (NIDDM). Biochem. Biophys. Res. Commun. 211: 833-839.
30. D'Alfonso S, Colombo G, Delia Bella S, Scorza R, Momigliano-Richiardi P. (1996) Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population. Tissue Antigens 47: 551-555.
31. Fong C-LW, Siddiqui AH, Mark DF. (1994) Identification and characterization of a novel repressor site in the human tumor necrosis factor a gene. Nucl. Add Res. 22: 1108-1114.
32. Udalova IA, Knight JC, Vidai V, Nedospasov SA, Kwiatkowski D. (1998) Complex NF-kappaB interactions at the distal tumor necrosis factor promoter region in human monocytes. J. Biol. Chem. 273: 21178-21186.
33. Bendtzen K, Morling N, Fomsgaard A, et al. (1988) Association between HLA-DR2 and production of tumour necrosis factor a and Interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand. J. Immunol. 28: 599-606.
34. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDcvitt HO. (1990) Heritable major hislocompatibility complex class II-associated differences in production of tumor necrosis factor a: relevance to genetic predisposition to systemic lupus erythemaiosus. Proc. Natl. Acad. Sci. U.S.A. 87: 1233-1237.
35. Philip R, Epstein LB. (1986) Tumour necrosis factor as immunomodulator and mediator of monocyte cytoloxicity induced by itself, γ-interferon and interleukin-1. Nature 323: 86-89.
36. Pociot F, D'Alfonso S, Compasso S, Scorza R, and Richiardi PM. ( 1995) Functional analysis of a new polymorphism in the human TNF α gene promoter. Scand. J. Immunol. 42: 501-504.
37. Wilson AG, de Vries N, Pociot F, Di Giovine FS, van der Putte LBA, Duff GW. (1993) An allelic polymorphism within the human tumor necrosis factor a promoter region is strongly associated with HLA Al, B8, and DR3 alleles. J. Exp. Med. 177: 557-560.
38. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D. (1994) Variation in the TNF-a promoter region associated with susceptibility to cerebral malaria. Nature 371: 508-511.
39. Cabrera M, Shaw MA, Sharpies C, et al. (1995) Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J. Exp. Med. 182: 1259-1264.
40. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. (1997) Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation. Proc. Natl. Acad. Sci. U.S.A. 94: 3195-3199.
41. Kroeger KM, Carville KS, Abraham LJ. ( 1997) The -308 tumor necrosis factor-α promoter polymorphism effects transcription. Mol. Immunol. 34: 391-399.
42. Stüber F, Udalova IA, Book M, et al. (1996) -308 Tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J. Inflam. 46: 42-50.
43. McDonnell PC, DiLella AG, Lee JC, Young PR. (1995) Localization of the human stress responsive MAP kinase-like CSAIDs binding protein (CSBP) gene to chromosome 6p21.3/21.1. Genomics 28: 301-302.
44. Albertella MR, Campbell RD. (1994) Characterization of a novel gene in the human major histocompatibility complex of the I kappa B family of proteins. Hum. Mol. Genet. 3: 793-799.
45. MilnerCM, Campbell RD. (1993) The G9a gene in the human major histocompatibility complex encodes a novel protein containing ankyrin-like repeats. Biochem. J. 290: 811-818.